Zichong Huang

Papers

1

Total Citations

86

H-Index

1

About

Zichong Huang is a leading figure in the field of stereotactic radiosurgery, with a particular focus on the treatment of early-stage lung cancer. His seminal 2007 paper, "CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months," which has garnered 86 citations, established a critical benchmark for non-invasive, high-precision radiation therapy. Huang's work was among the first to demonstrate the long-term efficacy and safety of CyberKnife radiosurgery for medically inoperable patients, showing three-year outcomes that rivaled those of traditional surgery. By meticulously documenting tumor control rates and toxicity profiles, he helped transform the standard of care for Stage I lung cancer, offering a viable alternative to lobectomy for a vulnerable patient population. His contributions have been instrumental in advancing the clinical adoption of stereotactic body radiation therapy (SBRT) and have shaped subsequent protocols in thoracic oncology. Huang's research continues to influence how clinicians balance curative intent with quality of life, solidifying his reputation as a pioneer in image-guided, non-invasive cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
86
Total Citations
86
Avg Citations/Paper
🏆 Most Cited Paper
CyberKnife® Radiosurgery for Stage I Lung Cancer: Results at 36 Months
86 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago